The use of chlorambucil with prednisone in the treatment of pemphigus

Journal of the American Academy of Dermatology

Volumn 42, Issue 1 I, 2000, Pages 85-88

  Shah, Neha ^a   Green, Andy R ^a   Elgart, George W ^a   Kerdel, Francisco ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DAPSONE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE;

ADJUVANT THERAPY; ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEDICAL RECORD; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033911929     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(00)90014-8     Document Type: Article

References (15)

1. Bystryn JC, Steinman MN.The adjuvant therapy of pemphigus. Arch Dermatol 1996;132:203-11.
2. Bach JF.The pharmacological and immunological basis for the use of immunosuppressive drugs. Drugs 1976;11:1-13.
3. Milligan A, Hutchinson PE.The use of chlorambucil in the treatment of bullous pemphigoid. J Am Acad Dermatol 1990;22:796-801.
4. Oktavijan PM, Peterson HD. Bum injury. In: Georgiade GS, Riefkohl R, Levin SL, editors. Plastic maxillofacial and reconstructive surgery. Baltimore: Williams & Wilkins; 1997. p. 199-206.
5. Lin MS, Mascaro JM Jr, Liu Z, Espana A, Diaz LA.The demosome and hemidesmosome in cutaneous autoimmunity. Clin Exp Immunol 1997;107S:9-15.
6. Wagoner LE, Taylor DO, Olsen SL, Bristow MR, O'Conell JB, Hammond EH, et al. Cyclophosphamide in cardiac transplant recipients with frequent rejection: a six-year retrospective review. Clin Transpl 1996;10:437-43.
7. Talar-Williams C, Hijazi YM, Walther MM, Linehan WM, Hallahan CW, Lubensky I, et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener's granulomatosis. Ann Intern Med 1996;124:477-84.
8. Callen JP. Immunosuppressive and cytotoxic drugs: uses in the dermatological patient. Adv Dermatol 1990;5:3-20.
9. Sabbour MS, Osman L. Comparison of chlorambucil, azathioprine or cyclophosphamide combined with corticosteroids in the treatment of lupus nephritis. Br J Dermatol 1979;100:113-25.
10. Sinoway PA, Callen JP. Chlorambucil: an effective corticosteroid-sparing agent for patients with recalcitrant dermatomyositis. Arthritis Rheum 1993;36:319-24.
11. Burruss JB, Farmer ER, Callen JP. Chlorambucil is an effective corticosteroid-sparing agent for recalcitrant pyoderma gangrenosum. J Am Acad Dermatol 1996;35:720-4.
12. Palmer RG, Denman AM. Malignancies induced by chlorambucil. Cancer Treat Rev 1984;11:121-9.
13. Kahn MF, Arlet J, Bloch-Michet H, Caroit M, Chaouat Y, Renier JC. Acute leukemia after treatment using cytotoxic agents for rheumatological purposes. Nouv Press Med 1979;8:1393-7.
14. French Cooperative Group on Chronic Lymphocytic Leukemia. Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (Stage A): results of a randomized clinical trial on 612 patients. Blood 1990;75:1414-21.
15. Rapini RP, Jordan RE, Wolverton SE. Cytotoxic agents. In: Wolverton SE, Wilkin JK, editors. Systemic drugs for skin diseases. Philadelphia: WB Saunders; 1991. p. 125-51.